MHC-binding peptides as immunotherapeutics for cancer

Immunol Invest. 2000 May;29(2):105-10. doi: 10.3109/08820130009062291.
No abstract available

MeSH terms

  • Antigens, Neoplasm / metabolism*
  • Carcinoembryonic Antigen / immunology
  • Cytotoxicity, Immunologic
  • Epitopes / metabolism
  • Histocompatibility Antigens Class I / metabolism*
  • Histocompatibility Antigens Class II / metabolism*
  • Humans
  • Immunotherapy / methods*
  • In Vitro Techniques
  • Neoplasm Proteins / immunology
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Peptides / immunology*
  • Peptides / metabolism*
  • Protein Binding
  • Receptor, ErbB-2 / immunology
  • T-Lymphocytes, Cytotoxic / immunology

Substances

  • Antigens, Neoplasm
  • Carcinoembryonic Antigen
  • Epitopes
  • Histocompatibility Antigens Class I
  • Histocompatibility Antigens Class II
  • MAGEB2 protein, human
  • Neoplasm Proteins
  • Peptides
  • Receptor, ErbB-2